Winton Group’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-10,745
Closed -$410K – 1283
2021
Q3
$410K Buy
10,745
+1,663
+18% +$66.2K 0.02% 959
2021
Q2
$364K Buy
9,082
+1,830
+25% +$77.3K 0.02% 1087
2021
Q1
$314K Buy
7,252
+1,858
+34% +$81.9K 0.02% 1124
2020
Q4
$232K Buy
+5,394
New +$197K 0.02% 1137
2018
Q3
– Sell
-6,418
Closed -$365K – 1106
2018
Q2
$365K Sell
6,418
-438
-6% -$24.9K 0.01% 750
2018
Q1
$403K Buy
+6,856
New +$384K 0.01% 866
2017
Q4
– Sell
-44,895
Closed -$2.12M – 695
2017
Q3
$2.12M Buy
+44,895
New +$2.11M 0.07% 320

Other funds holding OFIX

Winton Group's OFIX Position: Q4 2021 in Review

Winton Group sold out of Orthofix Medical (OFIX) in Q4 2021, closing a stake of 10,745 shares — an estimated $410K sold.

Winton Group first reported a position in OFIX in Q3 2017 and held it in 7 quarters. The position peaked at $2.12M in Q3 2017. 135 funds tracked by Wall St. Rank hold OFIX as of Q4 2021.

  • Winton Group reported no remaining Orthofix Medical position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 10,745 Orthofix Medical shares in Q4 2021, an estimated $410K.
  • Winton Group first reported a position in Orthofix Medical in Q3 2017 and held it in 7 quarters.
  • Winton Group's Orthofix Medical position peaked at $2.12M in Q3 2017.
  • 135 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.